Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Newly Appointed Alto Holdings CFO Gardner Takes Voting Control of Cancer Therapeutics Inc.

April 26th, 2010

Newly Appointed Alto Holdings CFO Gardner Takes Voting Control of Cancer Therapeutics Inc.

Abstract:
Cancer Therapeutics Inc. (OTC BB: CTHP) has issued 200 preferred shares to CEO-CFO Chene Gardner in lieu of one year's salary, giving him 70.39 percent voting control of the company, according to an 8-K filed today with the U.S. Securities and Exchange Commission.

Based in South Jordan, Utah, and with principal business offices in Thomasville, Ga., Cancer Therapeutics is a biotechnology business incubator that focuses on disruptive treatments and nanotechnology to develop drugs for the treatment of cancer.

Source:
citybizlist.com

Bookmark:

Related News Press

News and information

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013

Announcements

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013

Appointments/Promotions/New hires/Resignations/Deaths

Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013

SEMATECH Names William R. Rozich Chairman of the Board June 13th, 2013

David Neuschuler Joins RASIRC to Manage Engineering June 3rd, 2013

Asylum Research Announces Ben Ohler as AFM Business Manager May 29th, 2013

Financial Reports

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013

Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013

Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013